Director, Cardiovascular and metabolic diseases, Clinical Pharmacology Modeling and Simulation
GSK Baar Onyx US$188,100 – US$313,500 pa
Leads end-to-end Model-Informed Drug Development and clinical pharmacology strategy across the drug development lifecycle, from first-in-human studies through filing and lifecycle management. Sits in the Clinical Pharmacology and Quantitative Medicine organisation, partnering with digital medicine, translational imaging, modelling and biostatistics teams, and drafting regulatory content for FDA, EMA and ICH submissions.